(1) Only saliva and urinalysis testing instruments and vendors on the department's list of approved testing methodologies, instruments, and vendors may be used in the program.
(2) For purposes of this rule, the following definitions apply:
(a) "Confirmatory test" means the final drug test used to determine if a participant has violated the requirements of the program. If the participant does not admit use and chooses to perform a laboratory confirmation test, the laboratory confirmation test is considered a confirmatory test and the on-site analysis is considered an initial test. If the participant chooses not to run a laboratory confirmation test, the on-site test is considered the confirmatory test.
(b) "Initial test" means a first test that screens out compliant participants. If the initial test is non-negative, the participant is subject to a confirmatory test in urinalysis and oral swab testing unless the participant admits use.
(c) "Laboratory" means:
(i) a facility that receives and tests saliva and urine specimens to determine the presence of drugs; and
(ii) a facility with at least one of the following certifications or accreditations: Clinical Laboratory Improvement Amendment (CLIA); American Association for Laboratory Accreditation; American Osteopathic Association/Healthcare Facilities Accreditation Program (AOA/HFAP); College of American Pathologists (COLA); ANSI National Accreditation Board (ANAB); or The Joint Commission.
(d) "Non-negative test result" means a test result on an initial test that is greater than the cutoff level for a psychoactive substance or metabolite but is not confirmed as a positive test.
(e) "Positive test result" means a test result confirming the presence of a psychoactive substance or metabolite in a sample provided by a participant.
(3) The individual administering the saliva or urinalysis test shall collect specimens using a container from an approved vendor and send the container to a laboratory for testing if the testing protocol requires laboratory review. For each specimen requiring laboratory review, the individual administering the test shall complete a test-requisition and/or chain of custody form in accordance with industry standards.
(4) Required data from saliva and urinalysis testing must be promptly entered into the data management system. Required data includes:
(a) enrollment data as outlined in ARM 23.18.303(4);
(b) the program start date;
(c) the program end date;
(d) the reason for a participant's program enrollment;
(e) the name of the individual administering the test;
(f) the primary test site;
(g) the type of test; the oral fluid or urinalysis kit identification number;
(h) for a laboratory sample, the chain of custody number;
(i) the test status and result;
(j) the reason for the participant's program termination; and
(k) the date and time of the participant's program termination.